It is possible that a more complete knockdown of BDNF in 3xTg-AD mice may have led to an increase in amyloidogenic processing, however, the degree of knockdown achieved in the current experiment more closely models the deficits reported for AD patients [10]. The gene discussed is BDNF; the disease is Alzheimer disease.